Cash From Financing Activities - Kilitch Drugs (India) Ltd (NSE:KILITCH) - Alpha Spread
K

Kilitch Drugs (India) Ltd
NSE:KILITCH

Watchlist Manager
Kilitch Drugs (India) Ltd
NSE:KILITCH
Watchlist
Price: 335.1 INR -0.76% Market Closed
Market Cap: 5.4B INR
Have any thoughts about
Kilitch Drugs (India) Ltd?
Write Note

Kilitch Drugs (India) Ltd
Cash from Financing Activities

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Kilitch Drugs (India) Ltd
Cash from Financing Activities Peer Comparison

Comparables:
DRREDDY
CIPLA
SUNPHARMA
ZYDUSLIFE
T
TORNTPHARM

Competitive Cash from Financing Activities Analysis
Latest Figures & CAGR of Competitors

Company Cash from Financing Activities CAGR 3Y CAGR 5Y CAGR 10Y
K
Kilitch Drugs (India) Ltd
NSE:KILITCH
Cash from Financing Activities
â‚ą88.1m
CAGR 3-Years
76%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Dr Reddy's Laboratories Ltd
NSE:DRREDDY
Cash from Financing Activities
-â‚ą3.8B
CAGR 3-Years
-133%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Cipla Ltd
NSE:CIPLA
Cash from Financing Activities
-â‚ą12B
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Sun Pharmaceutical Industries Ltd
NSE:SUNPHARMA
Cash from Financing Activities
-â‚ą67.1B
CAGR 3-Years
-4%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Zydus Lifesciences Ltd
NSE:ZYDUSLIFE
Cash from Financing Activities
-â‚ą18.1B
CAGR 3-Years
11%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
T
Torrent Pharmaceuticals Ltd
NSE:TORNTPHARM
Cash from Financing Activities
-â‚ą27.8B
CAGR 3-Years
-19%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Kilitch Drugs (India) Ltd's Cash from Financing Activities?
Cash from Financing Activities
88.1m INR

Based on the financial report for Jun 30, 2024, Kilitch Drugs (India) Ltd's Cash from Financing Activities amounts to 88.1m INR.

What is Kilitch Drugs (India) Ltd's Cash from Financing Activities growth rate?
Cash from Financing Activities CAGR 3Y
76%

The average annual Cash from Financing Activities growth rates for Kilitch Drugs (India) Ltd have been 76% over the past three years .

Back to Top